Tempest Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Tempest Therapeutics

09/05/2024 23:45

* Tempest Therapeutics Inc  TPST.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -55 cents.  The mean expectation of six analysts
for the quarter was for a loss of 37 cents per share. Wall
Street expected results to range from -48 cents to -33 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Tempest Therapeutics Inc's reported EPS for the quarter
was a
loss of 36 cents​.
    * The company reported a quarterly loss of $7.9 million.
    * Tempest Therapeutics Inc shares had fallen by 11.3% this
quarter and lost 21.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Tempest
Therapeutics Inc is $14.00 
This summary was machine generated from LSEG data May 9 at 10:45
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.37          -0.36          Beat
 Dec. 31 2023      -0.39          -0.38          Beat
 Sep. 30 2023      -0.57          -0.48          Beat
 Jun. 30 2023      -0.52          -0.54          Missed